← SynDRA
SEMAPIMOD
SynDRA canonical compound SYN0033234 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | DHPS | MAPK14 | RAF1 |
|---|
| Mechanism of action | cytokine production inhibitor | p38 MAPK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
- cytokine production inhibitor
- RAF1 MODULATOR
Drug classes
- Anti-Inflammatory Agents, Non-Steroidal
- Immunosuppressive Agents
Cross-references
Synonyms
- Cni-1493
- Semapimod hydrochloride
- Semapimod tetrahydrochloride
- AXD-455
- CPSI-2364 FREE BASE
- CPSI-2364
- Semapimod (oral)
- Semapimod (oral), Cytokine PharmaSciences
- CNI 1493
- 9SGW2H1K8P
- AXD455
- CPSI 2364
- semapimodum
- RefChem:182336
- CPSI2364
- Semapimod [INN]
- UNII-9SGW2H1K8P
- AXD 455
- SCHEMBL12201344
- SCHEMBL18758868
- EBC-24099
- EX-A10388
- NCGC00487056-01
- DA-77787
- HY-15509
- CS-0006827
- NS00072955
- EN300-261068
- T79304
- Z2574937853
- A16WYQ522A
- HY-15509A
- Semapimod HCl
- UNII-A16WYQ522A
- GLXC-01899
- G14215
- SCHEMBL1649211
- C34H56Cl4N18O2
Look up SEMAPIMOD in the interactive SynDRA portal →